Agency Links:   Home  Contact Us   Help   Site Map
Link to Homepage

Patient/Public Info  |  Regional Services  |  Health Professionals Info  |  About BCCA  |  Research  |  Donating

CgA (Chromogranin "A")

Published:7 January 2004

Chromogranin "A" is a protein, located in neuroendocrine cells, which is co-secreted with a wide variety of peptide hormones and neurotransmitters. Tumours with neuroendocrine properties typically secrete large quantities of CgA into the circulation.  The assay is used primarily in the diagnosis and monitoring of patients with carcinoid tumours, islet cell tumours, pheochromocytoma, neuroblastoma, and other tumours of neuroendocrine origin.  It may also be used for small-cell lung cancer and prostate cancer, in men with normal PSA levels.

Non-malignant elevations may be seen in kidney, liver, or heart failure, It may also be elevated in patients experiencing significant stress because CgA is co-released with catecholamines.

CgA is measured using the DAKO ELISA double antibody sandwich assay.  The required sample is 1ml serum.  Aliquots should be shipped refrigerated or frozen.  Prior to shipping the serum can be kept refrigerated for up to one week, and frozen for 6-12 months.

Testing is performed monthly, but frequency may increase, depending on test volumes and clinical circumstances.

Reference Range: <40 U/L


The BC Cancer Agency is a part of the Provincial Health Services Authority .
If you notice a problem with this page, please report it via the Bug Report Form.
Copyright © 2010. BC Cancer Agency. All Rights Reserved. | Terms of Use | Privacy

Unofficial document if printed. Please refer to the following web address for up-to-date information: http://www.bccancer.bc.ca/HPI/CancerManagementGuidelines/TumourMarkers/CgA.htm